UNC researcher: Flawed study led to WHO decision against remdesivir

Ralph Baric, an epidemiologist at UNC-Chapel Hill whose research helped develop remdesivir, said the study the World Health Organization used to recommend against using the drug to treat COVID-19 had flaws.